Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Celecoxib"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3
Hee Jung Kim, Ga Won Yim, Eun Ji Nam, Young Tae Kim
Cancer Res Treat. 2014;46(1):81-92.   Published online January 15, 2014
DOI: https://doi.org/10.4143/crt.2014.46.1.81
AbstractAbstract PDFPubReaderePub
PURPOSE
Celecoxib, a highly selective cyclooxygenase-2 inhibitor, regulates apoptosis of several types of human cancer cells. The purpose of this study was to investigate whether celecoxib in combination with paclitaxel modulates apoptosis of ovarian cancer cells, and to identify the signal pathway by which celecoxib mediates apoptosis.
MATERIALS AND METHODS
OVCAR-3 cells were exposed to paclitaxel (20 microM) in the absence or presence of celecoxib (10 microM). Cell viability was evaluated using a Cell Counting Kit-8 assay. Apoptosis was evaluated using Annexin-V/7-aminoactinomycin D staining and a cellular DNA fragmentation enzyme-linked immunosorbent assay. Caspase-3, -9, and cleavage of poly ADP-ribose polymerase (PARP) were determined by western blotting. Expression of nuclear factor-kappaB (NF-kappaB) and vascular endothelial growth factor (VEGF) and Akt activation were assessed using reverse transcriptase-polymerase chain reaction and western blotting.
RESULTS
Celecoxib enhanced paclitaxel-induced growth inhibition of OVCAR-3 cells. Celecoxib significantly increased paclitaxel-induced apoptosis of OVCAR-3 cells. Pretreatment with celecoxib also increased activation of caspase-9, -3 and cleaved PARP following paclitaxel-treatment. Exposure of OVCAR-3 cells to celecoxib in combination with paclitaxel resulted in downregulation of NF-kappaB activation and VEGF expression. Furthermore, combining celecoxib and paclitaxel inhibited phosphorylation of Akt.
CONCLUSION
OVCAR-3 cells were sensitized to paclitaxel-induced apoptosis by celecoxib through downregulation of NF-kappaB and Akt activation, suggesting that celecoxib may work synergistically with paclitaxel to inhibit different targets and ultimately produce anticancer effects. Combining celecoxib with paclitaxel may prove beneficial in the clinical treatment of ovarian cancer.

Citations

Citations to this article as recorded by  
  • Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells
    Mohaddeseh Hedayat, Mohammad Rafi Khezri, Reza Jafari, Hassan Malekinejad, Naime Majidi Zolbanin
    Medical Oncology.2023;[Epub]     CrossRef
  • Hyperforin-mediated anticancer mechanisms in MDA-MB-231 cell line: insights into apoptotic mediator modulation and caspase activation
    Muttiah Barathan, Ahmad Khusairy Zulpa, Kumutha Malar Vellasamy, Zaridatul Aini Ibrahim, See Mee Hoong, Vanitha Mariappan, Gopinath Venkatraman, Jamuna Vadivelu
    Journal of Taibah University for Science.2023;[Epub]     CrossRef
  • Celecoxib Reverse Invasion and Metastasis of Gastric Cancer through Lnc_AC006548.28-miR-223-LAMC2 Pathway
    Guohua Jin, Jianguang Zhang, Tingting Cao, He Zhu, Yang Shi, Kapil Sharma
    Computational Intelligence and Neuroscience.2022; 2022: 1.     CrossRef
  • New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways
    Alma Martelli, Marzieh Omrani, Maryam Zarghooni, Valentina Citi, Simone Brogi, Vincenzo Calderone, Antoni Sureda, Shahrokh Lorzadeh, Simone C. da Silva Rosa, Beniamin Oscar Grabarek, Rafał Staszkiewicz, Marek J. Los, Seyed Fazel Nabavi, Seyed Mohammad Nab
    Cancers.2022; 14(23): 5839.     CrossRef
  • MicroRNA-758 Regulates Oral Squamous Cell Carcinoma via COX-2
    Gang Dong, Hong Chen, Yan Shi, Chunrong Jiang, Hongtao Yang
    Indian Journal of Surgery.2021; 83(4): 932.     CrossRef
  • Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines
    Mohammad Panji, Vahideh Behmard, Zahra Zare, Monireh Malekpour, Hasan Nejadbiglari, Saeede Yavari, Tina Nayerpour dizaj, Azadeh Safaeian, Ali Bakhshi, Omid Abazari, Mojtaba Abbasi, Parisa Khanicheragh, Maryam Shabanzadeh
    Gene.2021; 787: 145638.     CrossRef
  • Spike-in normalization for single-cell RNA-seq reveals dynamic global transcriptional activity mediating anticancer drug response
    Xin Wang, Jane Frederick, Hongbin Wang, Sheng Hui, Vadim Backman, Zhe Ji
    NAR Genomics and Bioinformatics.2021;[Epub]     CrossRef
  • Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
    Zhimin Shen, Mingduan Chen, Fei Luo, Hui Xu, Peipei Zhang, Jihong Lin, Mingqiang Kang
    Frontiers in Genetics.2021;[Epub]     CrossRef
  • Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition
    Lin Deng, Ding-qing Feng, Bin Ling
    Journal of Zhejiang University-SCIENCE B.2020; 21(4): 315.     CrossRef
  • Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
    Di Yu‐Wei, Zhuo‐sheng Li, Shu‐min Xiong, Ge Huang, Yan‐fei Luo, Tie‐ying Huo, Mao‐hua Zhou, You‐wei Zheng
    FEBS Open Bio.2020; 10(8): 1655.     CrossRef
  • Integration of genetic variants and gene network for drug repurposing in colorectal cancer
    Lalu Muhammad Irham, Henry Sung-Ching Wong, Wan-Hsuan Chou, Wirawan Adikusuma, Eko Mugiyanto, Wan-Chen Huang, Wei-Chiao Chang
    Pharmacological Research.2020; 161: 105203.     CrossRef
  • Correlation between the changes of serum COX 2, APE1, VEGF, TGF-β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment
    Qingxi Zhang, Guo Dong, Fuchuan Wang, Wenyuan Ding
    Journal of Cancer Research and Therapeutics.2020; 16(2): 335.     CrossRef
  • Preventative effect of celecoxib in dimethylbenz[a]anthracene-induced ovarian cancer in rats
    Zhuyan Shao, Qiang Wen, Tao Zhu, Wei Jiang, Yu Kang, Conjian Xu, Shihua Wang
    Archives of Gynecology and Obstetrics.2018; 298(5): 981.     CrossRef
  • Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
    Alessandra Pannunzio, Mauro Coluccia
    Pharmaceuticals.2018; 11(4): 101.     CrossRef
  • Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response
    Xiaobin Zheng, Neal Andruska, Michael J. Lambrecht, Sisi He, Amadeo Parissenti, Paul J. Hergenrother, Erik R. Nelson, David J. Shapiro
    Oncotarget.2018; 9(19): 14741.     CrossRef
  • MicroRNA-381 regulates the occurrence and immune responses of coronary atherosclerosis via cyclooxygenase-2
    Kaiyou Song, Lianting Li, Guiling Sun, Yanjin Wei
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Cyclooxygenase-2 mediated synergistic effect of ursolic acid in combination with paclitaxel against human gastric carcinoma
    Xian Xu, Guo-Qin Zhu, Kai Zhang, Yi-Chan Zhou, Xiao-Lin Li, Wei Xu, Hao Zhang, Yun Shao, Zhen-Yu Zhang, Wei-Hao Sun
    Oncotarget.2017; 8(54): 92770.     CrossRef
  • Literature-based discovery of new candidates for drug repurposing
    Hsih-Te Yang, Jiun-Huang Ju, Yue-Ting Wong, Ilya Shmulevich, Jung-Hsien Chiang
    Briefings in Bioinformatics.2016; : bbw030.     CrossRef
  • Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27
    Tülay BAKIREL, Fulya Üstün ALKAN, Oya ÜSTÜNER, Suzan ÇINAR, Funda YILDIRIM, Gaye ERTEN, Utku BAKIREL
    Journal of Veterinary Medical Science.2016; 78(4): 657.     CrossRef
  • Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
    Andrew J. Wilson, Oluwole Fadare, Alicia Beeghly-Fadiel, Deok-Soo Son, Qi Liu, Shilin Zhao, Jeanette Saskowski, Md. Jashim Uddin, Cristina Daniel, Brenda Crews, Brian D. Lehmann, Jennifer A. Pietenpol, Marta A. Crispens, Lawrence J. Marnett, Dineo Khabele
    Oncotarget.2015; 6(25): 21353.     CrossRef
  • 13,232 View
  • 120 Download
  • 25 Web of Science
  • 20 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP